--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "CURRENT Dx Tx Cardiology" developer_entity: "Skyscape Medpresso Inc" bundle_id: "com.medpresso.Lonestar.currcardio" app_store_id: "1551762345" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: true market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-07-01" report_date: "2026-08-06" last_verified: "2026-08-06T00:00:00.000Z" report_version: "5.9.2" total_reviews: 4 overall_rating: 4.8 sentiment: "Excited" sentiment_score: 65 confidence: "medium" confidence_score: 0.55 top_praise_theme: "Medical professionals find the quick reference format helpful for daily clinical practice and cardiology study" top_complaint_theme: "Users express dissatisfaction with the overall experience provided by the application in its current state" review_sample_size: 4 total_review_count: 4 analyzed_review_count: 4 data_age_days: 10 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "excited sentiment", "mobile app", "app review", "app analysis", "cardiologists,", "internal", "medicine"] canonical_url: "https://marlvel.ai/apps/current-dx-tx-cardiology" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # CURRENT Dx Tx Cardiology Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.75 · Sentiment Excited - **Recent focus**: Users express dissatisfaction with the overall experience provided by the application in its current state (top complaint) · Medical professionals find the quick reference format helpful for daily clinical practice and cardiology study (top praise) > **TL;DR:** CURRENT Dx Tx Cardiology is a medical app by Skyscape Medpresso Inc, rated 4.75/5 by 4 users, with Excited user sentiment (65/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** CURRENT Dx Tx Cardiology maintains Excited user sentiment (4.75/5 from 4 reviews), with users consistently praising medical professionals find the quick reference format helpful for daily clinical practice and cardiology study. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.75/5 (4 reviews) | | **User Mood** | Excited | | **Category** | Medical | | **Developer** | Skyscape Medpresso Inc | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.55/1.0) | | **Data Age** | 10d | ## Metadata & Market Performance - **Publisher:** Skyscape Medpresso Inc - **Category:** Medical - **Target Audience:** Cardiologists, internal medicine residents, and medical students preparing for ABIM certification exams. - **Platforms:** iOS & Android - **Version Reviewed:** 5.9.2 - **Report Date:** 2026-08-06 - **Signal Count:** 4 reviews analyzed - **Confidence:** Medium (0.55/1.0) - **App Store ID (iOS):** 1551762345 - **Bundle ID:** com.medpresso.Lonestar.currcardio - **Google Play ID:** com.medpresso.Lonestar.currcardio - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-06 ## Executive Snapshot **What it is:** CURRENT Dx Tx Cardiology is a medical reference app for cardiologists and residents, providing structured diagnostic and treatment protocols on iOS and Android. **Why users hire it:** The app removes the need for internet connectivity in clinical settings, allowing practitioners to access authoritative LANGE-format guidelines during patient care. ## App DNA (Features & Intent) - **[Standard] Clinical Reference Content:** Structured cardiology reference covering diagnostic techniques, prevention, treatment, and prognosis. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Offline Access:** Full content availability without internet connection, removing hospital connectivity dependencies. * *User Intent:* Users want uninterrupted access without internet dependency. - **[Standard] SmartSearch Technology:** Search functionality supporting partial terms for complex medical terminology. * *User Intent:* Users want to quickly find relevant content or features. ## Market Position {#market-position} CURRENT Dx Tx Cardiology maintains a specialized position in the medical reference category, leveraging the LANGE brand to serve professional users. The $89.99 annual price point positions the app as a premium tool, contrasting with the free, web-based clinical guidelines frequently used by students. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free sample content, $89.99/year auto-renewing subscription - **Analysis:** The $89.99/year price point gates the full clinical reference, creating a high barrier for medical students. ## 🟢 User Sentiment (Medium Confidence: 4 of 4 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.75/5 - **Platform Split:** iOS 4.8/5 (4 ratings) - **Overall Sentiment:** Excited ### Top Praises - **Medical professionals find the quick reference format helpful for daily clinical practice and cardiology study** ### Top Complaints (Impact Areas) - **Users express dissatisfaction with the overall experience provided by the application in its current state** ## SWOT Analysis {#swot} **Core Strengths:** - LANGE-format structure provides authoritative, standardized reference material for ABIM certification **Growth Levers:** - Tiered student pricing could capture the early-career segment currently priced out ## Recent Changes (v2 → v3) {#recent-changes} Strategic focus has shifted toward defending the premium price point as a quality signal while prioritizing the development of a student-tier subscription to address competitive pressure from free, open-access alternatives. **Overall trend**: Stable **Compared at**: 2026-08-06 ### High-impact changes - **[Shifted] Contrarian take pivot** (positioning) ### Medium-impact changes - **[Shifted] Weakness definition** (swot) - **[Shifted] Roadmap prioritization** (pricing) ## What's New - **Latest (v3.13.1.1, 1 months ago):** Updated to 6th Edition guidelines, adding chapters on Cardio-Oncology and Dilated Cardiomyopathy, expanded pacing device coverage, COVID-19 myocarditis data, and 200+ clinical images. ## App Momentum (Maintenance) {#momentum} - Shipped 6th edition clinical content. - Ships ~10 releases per year. > **Cadence:** 2 total versions · 2 majors in last 6 months · 35 days since last update · 0 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} CURRENT Dx Tx Cardiology is a medical app. It holds a 4.75/5 rating from 4 reviews. > **Bottom Line:** Transitioning to a tiered access model for medical students would address the primary barrier to adoption, potentially increasing the user base without cannibalizing the professional segment. **Best for:** Cardiologists, internal medicine residents, and medical students preparing for ABIM certification exams. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship a student-tier subscription because the current $89.99/year price is the top barrier for residents → increase user acquisition ### Outlook: Stable The medical reference market is shifting toward open-access, web-based guidelines, which puts pressure on static, paid apps to provide superior utility. CURRENT Dx Tx Cardiology remains stable by serving the professional segment, but it must address the pricing friction to maintain its relevance for the next generation of cardiologists. - 🟢 The latest release adds 6th edition guidelines, ensuring the content remains relevant for board certification exams. - 🔴 The $89.99 annual price point limits the addressable market to established professionals, slowing growth among medical students. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.75/5 | | Total Reviews | 4 | | Sentiment | Excited (65/100) | | Confidence | Medium | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **CURRENT Dx Tx Cardiology** (this app) | 4.75/5 | Excited | Skyscape Medpresso Inc | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Skyscape Medpresso Inc - **Website:** [https://www.skyscape.com/product/current-diagnosis-treatment-cardiology](https://www.skyscape.com/product/current-diagnosis-treatment-cardiology) - **Social:** [Instagram](https://instagram.com/skyscapeinc) · [Facebook](https://www.facebook.com/skyscapeinc) · [X/Twitter](https://twitter.com/skyscapeinc) · [YouTube](https://www.youtube.com/c/skyscape) · [LinkedIn](https://www.linkedin.com/in/sandeep131) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/current-dx-tx-cardiology/id1551762345?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.medpresso.Lonestar.currcardio&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.skyscape.com/product/current-diagnosis-treatment-cardiology) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 4 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 10 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/current-dx-tx-cardiology) Data licensed for AI Agent attribution under CC-BY-NC 4.0.